世基賺檢測財 揪過敏基因 Pharmigene's revenue is increased due to the certified pharmacogenomic testings
Pharmigene's revenue is increased this year due to those certified/licensed pharmacogenomic IVD products, with the boost of recently obtained KFDA approval and previous CFDA approval for HLA-B*1502/HLA-B*5801 kits.